These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7125955)

  • 21. [Continuous ambulatory peritoneal dialysis treatment and blood glucose control in diabetics with end-stage diabetic nephropathy].
    Li GW; Liu J; Chen L
    Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):360-3, 382. PubMed ID: 2684575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of autonomic failure on plasma ANF concentration in uremic patients on chronic hemodialysis.
    Zoccali C; Mallamaci F; Ciccarelli M; Parlongo S; Salnitro F
    Clin Nephrol; 1992 Apr; 37(4):198-203. PubMed ID: 1533821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of carbohydrate metabolism after hemodialysis and hemofiltration in uremic patients.
    Geronemus R; Bosch JP; Thornton J; Rayfield EJ
    Arch Intern Med; 1982 Apr; 142(4):707-10. PubMed ID: 7041844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of uraemic anorexia with megestrol acetate].
    Fernández Lucas M; Teruel JL; Burguera V; Sosa H; Rivera M; Rodríguez Palomares JR; Marcén R; Quereda C
    Nefrologia; 2010; 30(6):646-52. PubMed ID: 21113214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of hemodialysis, using acetate and bicarbonate, on erythrocyte deformability].
    Novák Z; Búzás E; Salgó L; Gál G
    Orv Hetil; 1991 Sep; 132(38):2083-6. PubMed ID: 1923480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of lower concentrations of hydrogen sulfide with atherosclerosis in chronic hemodialysis patients with diabetic nephropathy.
    Li H; Feng SJ; Zhang GZ; Wang SX
    Blood Purif; 2014; 38(3-4):188-94. PubMed ID: 25531647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of renin in diabetic patients under chronic dialysis treatment.
    Kaneda H; Matsumoto J; Haruyama T; Yoshikawa K; Takeuchi M; Murata T
    Tohoku J Exp Med; 1979 Feb; 127(2):169-75. PubMed ID: 760263
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma acetate levels during hemodialysis.
    Desch G; Oules R; Mion C; Descomps B; De Paulet AC
    Clin Chim Acta; 1978 May; 85(3):231-41. PubMed ID: 657519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of the artificial pancreas in uremic diabetic patients.
    Slama G; Klein JC; Delage A; Rottembourg J; Marouani A; Jacobs C
    Horm Metab Res Suppl; 1979; (8):178-83. PubMed ID: 395076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of acetate and bicarbonate hemodialysis on cardiac function in chronic dialysis patients.
    Mehta BR; Fischer D; Ahmad M; Dubose TD
    Kidney Int; 1983 Dec; 24(6):782-7. PubMed ID: 6325799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical availability of serum fructosamine measurement in diabetic patients with uremia. Use as a glycemic index in uremic diabetes.
    Shoji T; Tabata T; Nishizawa Y; Kikunami K; Matsushita Y; Inoue T; Kenmotsu M; Miki T; Morii H
    Nephron; 1989; 51(3):338-43. PubMed ID: 2918945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of growth hormone on glucose and acetate metabolism in sheep.
    Laarveld B; Kerr DE; Brockman RP
    Comp Biochem Physiol A Comp Physiol; 1986; 83(3):499-502. PubMed ID: 2870845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-specificity of arginine infusion as a test for growth-hormone secretion.
    Best J; Catt KJ; Burger HG
    Lancet; 1968 Jul; 2(7560):124-6. PubMed ID: 4173258
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of the uremic diabetic.
    Shyh TP; Beyer MM; Friedman EA
    Nephron; 1985; 40(2):129-38. PubMed ID: 3889674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP; Christensen SE; Lundbaek K
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatostatin-28 and somatostatin-14 suppression of arginine-, insulin-, and TRH-stimulated GH and PRL secretion in man.
    Millar RP; Klaff LJ; Barron JL; Levitt NS; Ling N
    Clin Endocrinol (Oxf); 1983 Mar; 18(3):277-85. PubMed ID: 6134596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium acetate versus calcium carbonate and erythropoietin dosages in haemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Nephrol Dial Transplant; 1995 Dec; 10(12):2321-4. PubMed ID: 8808233
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessing glycemic control in patients with diabetes and end-stage renal failure.
    Ansari A; Thomas S; Goldsmith D
    Am J Kidney Dis; 2003 Mar; 41(3):523-31. PubMed ID: 12612974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HbA1c is related with uremic pruritus in diabetic and nondiabetic hemodialysis patients.
    Afsar B; Elsurer Afsar R
    Ren Fail; 2012; 34(10):1264-9. PubMed ID: 21370992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute effects of hemodialysis on erythrocyte sodium fluxes in uremic patients.
    Quarello F; Boero R; Guarena C; Rosati C; Giraudo G; Giacchino F; Piccoli G
    Nephron; 1985; 41(1):22-5. PubMed ID: 2412141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.